SENP1

Sentrin-specific protease 1 · Q9P0U3 · SENP1 on Sugi Atlas →

19,678 patent compounds predicted against SENP1, 11,915 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL485085 SCHEMBL485085 0.58 19/20
SCHEMBL485651 SCHEMBL485651 0.57 19/20
SCHEMBL485276 SCHEMBL485276 0.46 19/20
SCHEMBL485260 SCHEMBL485260 0.56 18/20
SCHEMBL485298 SCHEMBL485298 0.56 18/20
SCHEMBL484955 SCHEMBL484955 0.47 18/20
SCHEMBL485732 SCHEMBL485732 0.46 18/20
SCHEMBL485458 SCHEMBL485458 0.59 17/20
SCHEMBL485661 SCHEMBL485661 0.47 17/20
SCHEMBL1000592 SCHEMBL1000592 0.50 16/20
SCHEMBL1230808 SCHEMBL1230808 0.50 14/20
SCHEMBL1023993 SCHEMBL1023993 0.58 10/20
SCHEMBL1382397 SCHEMBL1382397 0.47 10/20
SCHEMBL1000593 SCHEMBL1000593 0.49 7/20
SCHEMBL110923 SCHEMBL110923 0.54 6/20
SCHEMBL110924 SCHEMBL110924 0.54 6/20
SCHEMBL1436156 SCHEMBL1436156 0.54 6/20
SCHEMBL1436155 SCHEMBL1436155 0.53 6/20
SCHEMBL414245 SCHEMBL414245 0.52 6/20
SCHEMBL347478 SCHEMBL347478 0.49 6/20

Clinical trials — most relevant to SENP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER PHASE2/PHASE3RECRUITING
Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety PHASE2NOT_YET_RECRUITING
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors PHASE1COMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors nanNOT_YET_RECRUITING
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear nanUNKNOWN
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study nanCOMPLETED
Expression and Clinical Significance of IGHD in Pancreatic Cancer nanUNKNOWN
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Genetic Analysis to Predict the Development of Paget's Disease nanACTIVE_NOT_RECRUITING
Genetic Basis of Mitral Valve Prolapse nanUNKNOWN
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men nanRECRUITING
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment nanUNKNOWN
Biological Markers in Parkinson's Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SENP1 binder may also engage these)

ProteinNameSimilarity
Q5RBB1 1.000 Q5RBB1 →
P59110 0.998 P59110 →
SENP2 Sentrin-specific protease 2 0.993 landscape →
Q5R7K7 0.992 Q5R7K7 →
P46200 0.991 P46200 →
P10244 0.991 P10244 →
A6QP06 0.990 A6QP06 →
Q2PFD7 0.989 Q2PFD7 →
Q9EQE1 0.989 Q9EQE1 →
MAP3K13 Mitogen-activated protein kinase kinase kinase 13 0.989 landscape →
Q91ZX6 0.989 Q91ZX6 →
Q6EEF3 0.989 Q6EEF3 →
B2GUY1 0.989 B2GUY1 →
CDKL5 Cyclin-dependent kinase-like 5 0.989 landscape →
Q76I79 0.988 Q76I79 →
Q8NEM8 0.988 Q8NEM8 →
Q3YC04 0.988 Q3YC04 →
Q811D2 0.988 Q811D2 →
Q5TKR9 0.988 Q5TKR9 →
Q9Z1J2 0.988 Q9Z1J2 →
Q92539 0.988 Q92539 →
BLM RecQ-like DNA helicase BLM 0.988 landscape →
Q9NYI0 0.988 Q9NYI0 →
O43310 0.988 O43310 →
A0A1L8HFX9 0.987 A0A1L8HFX9 →
Q9SB51 0.987 Q9SB51 →
Q6NRK3 0.987 Q6NRK3 →
Q949U2 0.987 Q949U2 →
KMT5B Histone-lysine N-methyltransferase KMT5B 0.987 landscape →
Q9NQW6 0.987 Q9NQW6 →